Concepedia

Ashleigh E. Gibson

AE

Statistics

Publications

8

Citations

795

H-Index

8

Active since

1999

Affiliations

AstraZeneca (United Kingdom)(Current)

Newcastle University

University of Oxford

Ashleigh E. Gibson is an author at AstraZeneca (United Kingdom) specializing in ligand binding, medicinal chemistry, and drug discovery.

Publications per year

1999–2004

8

Publications

8

Identification of Novel Purine and Pyrimidine Cyclin-Dependent Kinase Inhibitors with Distinct Molecular Interactions and Tumor Cell Growth Inhibition Profiles

Christine E. Arris, F. Thomas Boyle, A. Hilary Calvert et al. · Journal of Medicinal Chemistry · 2000 · 216 citations · Full text

, , +14

Structure-based design of a potent purine-based cyclin-dependent kinase inhibitor

Thomas G. Davies, Johanne Bentley, Christine E. Arris et al. · Nature Structural Biology · 2002 · 214 citations

, , +14

N<sup>2</sup>-Substituted <i>O</i><sup>6</sup>-Cyclohexylmethylguanine Derivatives:  Potent Inhibitors of Cyclin-Dependent Kinases 1 and 2

Ian R. Hardcastle, Christine E. Arris, Johanne Bentley et al. · Journal of Medicinal Chemistry · 2004 · 124 citations · Full text

, , +15

Probing the ATP Ribose-Binding Domain of Cyclin-Dependent Kinases 1 and 2 with<i>O</i><sup>6</sup>-Substituted Guanine Derivatives

Ashleigh E. Gibson, Christine E. Arris, Johanne Bentley et al. · Journal of Medicinal Chemistry · 2002 · 85 citations · Full text

, , +13

4-Alkoxy-2,6-diaminopyrimidine derivatives: inhibitors of cyclin dependent kinases 1 and 2

Véronique Mesguiche, Rachel Parsons, Christine E. Arris et al. · Bioorganic & Medicinal Chemistry Letters · 2003 · 53 citations · Full text

, , +9

1–5 of 8